The document discusses FDA-approved anabolic-androgenic steroids (AAS) and their various clinical uses, particularly in treating specific conditions like HIV-related wasting syndrome and muscle atrophy. It describes the classifications and mechanisms of action of AAS, along with their potential therapeutic benefits and adverse effects. Additionally, it highlights the significance of compounds like nandrolone and oxandrolone, detailing their research findings in clinical settings.